Somatic Genitourinary Cancer Taskforce

The Genitourinary Cancer Taskforce will embark on variant curation for FGFR and PARP inhibitor pathways, using Clinical Interpretations of Variants in Cancer (CIViC) platform for variant curation.  The somatic variants should be examined and curated for the clinical significance/clinical management of patients, i.e. their role in the diagnosis, prognosis, therapeutic outcomes, prevention of the disease, or disease surveillance.

Somatic Cancer Subgroup

The GU taskforce is currently accepting members to join the team and support its variant curation and interpretation activities.


Please contact a coordinator if you have questions.

Working Group Membership

Membership spans many fields, including genetics, medical, academia, and industry.